Inventor · disambiguated record
Steven L. Colletti
Also filed as: COLLETTI STEVEN · COLLETTI STEVEN L
40 granted patents·25 pending applications·356 citations·filing 2001–2022
97Inventor score
Files withSIRNA THERAPEUTICS INC21COLLETTI STEVEN L10MERCK SHARP & DOHME8MERCK & CO INC4RAGHAVAN SUBHAREKHA3
Top patents by PatentIndex Score
65 records- 0198US9604908B2Diether based biodegradable cationic lipids for siRNA deliverySIRNA THERAPEUTICS INC·Filed 2016·Granted Mar 28, 2017·39 cites·6 claims
- 0297US9029590B2Low molecular weight cationic lipids for oligonucleotide deliveryCOLLETTI STEVEN L·Filed 2011·Granted May 12, 2015·43 cites·4 claims
- 0396US9458090B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2015·Granted Oct 4, 2016·9 cites·17 claims
- 0496US9402816B2Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2013·Granted Aug 2, 2016·10 cites·7 claims
- 0596US8748667B2Low molecular weight cationic lipids for oligonucleotide deliveryBUDZIK BRIAN W·Filed 2011·Granted Jun 10, 2014·96 cites·3 claims
- 0696US6399786B1Nonacyclic nodulisporic acid derivativesMERCK & CO INC·Filed 2001·Granted Jun 4, 2002·63 cites·17 claims
- 0793US9643916B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2016·Granted May 9, 2017·5 cites·6 claims
- 0893US8802863B2Amino alcohol cationic lipids for oligonucleotide deliveryBUDZIK BRIAN W·Filed 2011·Granted Aug 12, 2014·10 cites·4 claims
- 0990US9062021B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2014·Granted Jun 23, 2015·6 cites·6 claims
- 1088US11117917B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2019·Granted Sep 14, 2021·2 cites·20 claims
- 1188US10532068B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Jan 14, 2020·3 cites·18 claims
- 1288US9315437B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2015·Granted Apr 19, 2016·3 cites·6 claims
- 1387US9446132B2Diether based biodegradable cationic lipids for siRNA deliverySIRNA THERAPEUTICS INC·Filed 2013·Granted Sep 20, 2016·4 cites·7 claims
- 1486US9540639B2Tetragalnac containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted Jan 10, 2017·10 cites·22 claims
- 1585US9932311B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted Apr 3, 2018·4 cites·24 claims
- 1684US10221205B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·3 cites·20 claims
- 1784US9670487B2Cationic lipids for oligonucleotide deliveryCOLLETTI STEVEN L·Filed 2011·Granted Jun 6, 2017·4 cites·7 claims
- 1884US9655976B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2013·Granted May 23, 2017·6 cites·35 claims
- 1983US8987377B2Poly(amide) polymers for the delivery of oligonucleotidesBARRETT STEPHANIE E·Filed 2011·Granted Mar 24, 2015·7 cites·18 claims
- 2082US10010562B2Dual molecular delivery of oligonucleotides and peptide containing conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Jul 3, 2018·3 cites·20 claims
- 2178US9044512B2Amino alcohol cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2014·Granted Jun 2, 2015·1 cites·8 claims
- 2277US12304925B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2021·Granted May 20, 2025·0 cites·20 claims
- 2374US6586452B1C1 to C4 side chain modified nodulisporic acid analogsMERCK & CO INC·Filed 2001·Granted Jul 1, 2003·7 cites·10 claims
- 2473US7196095B2(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compoundsMERCK & CO INC·Filed 2002·Granted Mar 27, 2007·8 cites·25 claims
- 2572US8691580B2Single chemical entities and methods for delivery of oligonucleotidesAARONSON JEFFREY G·Filed 2011·Granted Apr 8, 2014·2 cites·6 claims
- 2671US8455520B2Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatmentCOLLETTI STEVEN L·Filed 2008·Granted Jun 4, 2013·1 cites·21 claims
- 2771US7411073B2Selective non-steroidal glucocorticoid receptor modulatorsMERCK & CO INC·Filed 2004·Granted Aug 12, 2008·5 cites·11 claims
- 2867US10968193B2Antidiabetic bicyclic compoundsMERCK SHARP & DOHME·Filed 2015·Granted Apr 6, 2021·1 cites·11 claims
- 2967US9840531B2Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Granted Dec 12, 2017·0 cites·21 claims
- 3067US2018208545A1Novel low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3166US9981907B2Low molecular weight cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2016·Granted May 29, 2018·0 cites·17 claims
- 3265US10307378B2Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2017·Granted Jun 4, 2019·0 cites·9 claims
- 3365US9861589B2Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide deliverySIRNA THERAPEUTICS INC·Filed 2016·Granted Jan 9, 2018·0 cites·17 claims
- 3465US8507473B23H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disordersBOATMAN P DOUGLAS·Filed 2009·Granted Aug 13, 2013·1 cites·26 claims
- 3560US2024140992A1Hexadepsipeptide compounds and methods of using the sameLODO THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 3659US2023049048A1Methods and apparatus for efficient and accurate assembly of long-read genomic sequencesLODO THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 3758US2017137815A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3855US2016074525A1Novel single chemical entities and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3954US2013253168A1Novel single chemical entities and methods for delivery of oligonucleotidesCOLLETTI STEVEN L·Filed 2011·Application pending·0 cites
- 4054US2011003849A1Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatmentSHEN HONG·Filed 2009·Application pending·0 cites
- 4153US2011039860A1Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatmentYANG CANGMING·Filed 2009·Application pending·0 cites
- 4251US8637555B2Tetrazole derivatives and methods of treatment of metabolic-related disorders thereofSEMPLE GRAEME·Filed 2004·Granted Jan 28, 2014·0 cites·2 claims
- 4348US8168649B2Niacin receptor agonists, compositions containing such compounds and methods of treatmentRAGHAVAN SUBHAREKHA·Filed 2006·Granted May 1, 2012·0 cites·20 claims
- 4448US2010204278A1Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of TreatmentBERESIS RICHARD T·Filed 2007·Application pending·0 cites
- 4547US10239957B2Peptide containing conjugates for dual molecular delivery of oligonucleotidesMERCK SHARP & DOHME·Filed 2014·Granted Mar 26, 2019·0 cites·1 claims
- 4647US7662846B2Selective spirocyclic glucocorticoid receptor modulatorsMERCK SHARP & DOHME·Filed 2004·Granted Feb 16, 2010·0 cites·5 claims
- 4746US10519115B2Antidiabetic tricyclic compoundsMERCK SHARP & DOHME·Filed 2014·Granted Dec 31, 2019·0 cites·21 claims
- 4846US10214742B2Tetragalnac containing conjugates and methods for delivery of oligonucleotidesSIRNA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·0 cites·20 claims
- 4946US2003078369A1Apicidin-derived cyclic tetrapeptidesFiled 2002·Application pending·0 cites
- 5046US2007072924A1Tetrazole derivatives and methods of treatment of metabolic-related disorders thereofSEMPLE GRAEME·Filed 2006·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →